Summary

Endoscopic Stricture Management Device Market – Scope of Report
TMR’s report on the global endoscopic stricture management devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global endoscopic stricture management devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global endoscopic stricture management devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the endoscopic stricture management devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global endoscopic stricture management devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global endoscopic stricture management devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global endoscopic stricture management devices market.

The report delves into the competitive landscape of the global endoscopic stricture management devices market. Key players operating in the global endoscopic stricture management devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global endoscopic stricture management devices market profiled in this report.

Key Questions Answered in Global endoscopic stricture management devices Market Report
• What is the sales/revenue generated by endoscopic stricture management devices across all regions during the forecast period?
• What are the opportunities in the global endoscopic stricture management devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Endoscopic Stricture Management Device Market – Research Objectives and Research Approach
The comprehensive report on the global endoscopic stricture management devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global endoscopic stricture management devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global endoscopic stricture management devices market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Endoscopic Stricture Management Device Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Endoscopic Stricture Management Device Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Endoscopic Stricture Management Device Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Balloon Dilators
6.3.1.1. Balloon Dilator Catheters
6.3.1.2. Balloon Inflation Devices
6.3.2. Stents
6.3.2.1. Metal Stents
6.3.2.2. Plastic Stents
6.3.2.3. Biodegradable Stents
6.3.3. Bougie Dilators
6.4. Market Attractiveness Analysis, by Product
7. Global Endoscopic Stricture Management Device Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Esophageal
7.3.2. Colonic
7.3.3. Pyloric
7.3.4. Biliary
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Endoscopic Stricture Management Device Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Endoscopic Stricture Management Device Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Endoscopic Stricture Management Device Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Balloon Dilators
10.3.1.1. Balloon Dilator Catheters
10.3.1.2. Balloon Inflation Devices
10.3.2. Stents
10.3.2.1. Metal Stents
10.3.2.2. Plastic Stents
10.3.2.3. Biodegradable Stents
10.3.3. Bougie Dilators
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Esophageal
10.4.2. Colonic
10.4.3. Pyloric
10.4.4. Biliary
10.4.5. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Endoscopic Stricture Management Device Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Balloon Dilators
11.3.1.1. Balloon Dilator Catheters
11.3.1.2. Balloon Inflation Devices
11.3.2. Stents
11.3.2.1. Metal Stents
11.3.2.2. Plastic Stents
11.3.2.3. Biodegradable Stents
11.3.3. Bougie Dilators
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Esophageal
11.4.2. Colonic
11.4.3. Pyloric
11.4.4. Biliary
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Endoscopic Stricture Management Device Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Balloon Dilators
12.3.1.1. Balloon Dilator Catheters
12.3.1.2. Balloon Inflation Devices
12.3.2. Stents
12.3.2.1. Metal Stents
12.3.2.2. Plastic Stents
12.3.2.3. Biodegradable Stents
12.3.3. Bougie Dilators
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Esophageal
12.4.2. Colonic
12.4.3. Pyloric
12.4.4. Biliary
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Endoscopic Stricture Management Device Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Balloon Dilators
13.3.1.1. Balloon Dilator Catheters
13.3.1.2. Balloon Inflation Devices
13.3.2. Stents
13.3.2.1. Metal Stents
13.3.2.2. Plastic Stents
13.3.2.3. Biodegradable Stents
13.3.3. Bougie Dilators
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Esophageal
13.4.2. Colonic
13.4.3. Pyloric
13.4.4. Biliary
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Endoscopic Stricture Management Device Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product, 2017–2031
14.3.1. Balloon Dilators
14.3.1.1. Balloon Dilator Catheters
14.3.1.2. Balloon Inflation Devices
14.3.2. Stents
14.3.2.1. Metal Stents
14.3.2.2. Plastic Stents
14.3.2.3. Biodegradable Stents
14.3.3. Bougie Dilators
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Esophageal
14.4.2. Colonic
14.4.3. Pyloric
14.4.4. Biliary
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Olympus Corporation
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Boston Scientific Corporation
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Cook
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. CONMED Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Medi-Globe GmbH
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Hobbs Medical, Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. PanMed Us
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Merit Medical Systems.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Becton, Dickinson and Company
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview